PEDS25: Pediatric Psoriasis: Emerging Oral Options: An Online Activity

Released on

July 24, 2025

Earn up to

0.25 AMA PRA Category 1 Credit™

This 15-minute DermDash from the 2025 Pediatrics360 Virtual Conference explores the place of oral systemic therapies in the therapeutic landscape for pediatric psoriasis management, as well as evidence-based guidance for incorporating these therapies into care.

“We have older (oral) treatments that have some efficacy but there definitely is need for laboratory monitoring of these drugs. That requires blood work and kids may not like that… We use injectable treatments predominantly for fairly severe patients… the bottom-line is kids don’t like needles. Looking forward, oral treatments that are effective may be the next option for our patients with psoriasis.” – Dr. Boni Elewski

PEDS25: Pediatric Psoriasis: Emerging Oral Options: An Online Activity

This activity is supported by an educational grant from Amgen.

PEDS25: Pediatric Psoriasis: Emerging Oral Options: An Online Activity

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures